Action JAZZ PHARMACEUTICALS, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription
Instrument Inactif

Communiqués Jazz Pharmaceuticals, Inc. Nasdaq

Actions

US4721471070

Cours en clôture Nasdaq
Autres places de cotation
- USD - Graphique intraday de Jazz Pharmaceuticals, Inc.
10/07 Jazz Pharmaceuticals plc promeut Samantha Pearce au poste de Chief Commercial Officer CI
20/06 JAZZ PHARMACEUTICALS PLC : Needham & Co. persiste à l'achat ZM

Communiqués

Recherche
Voir les résultats
Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !
Inscription 100% Gratuite
Jazz Pharmaceuticals Hosts Discussion of Healthcare Inequities in the U.S. To Honor Juneteenth
AQ
Jazz Pharmaceuticals Promotes Samantha Pearce to Chief Commercial Officer
PR
Jazz Pharmaceuticals Publishes 2023 Corporate Sustainability and Social Impact Report: Progress, Responsibility and Innovation
AQ
Jazz Pharmaceuticals Provides Update on Phase 2b Trial of Investigational Suvecaltamide (JZP385) in Essential Tremor
PR
Jazz Pharmaceuticals : 2023 Annual Report
PU
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)
AQ
Jazz Pharmaceuticals plc - Zanidatamab Granted Priority Review for HER2-Positive Metastatic Biliary Tract Cancer
AQ
Jazz Pharmaceuticals Showcases Pioneering Research in Sleep Medicine at SLEEP 2024
PR
Jazz Pharmaceuticals to Participate in Upcoming June Investor Conferences
PR
Jazz Pharmaceuticals Announces Collaboration with Life Science Cares to Improve the Wellbeing of Under Resourced Communities through Employee Volunteerism
PR
Jazz Pharmaceuticals : Corporate Overview
PU
Jazz Pharmaceuticals : Announces First Quarter 2024 Financial Results
PU
Jazz: Q1 Earnings Snapshot
AQ
Jazz Pharmaceuticals to Participate in the BofA Securities 2024 Health Care Conference
PR
Jazz Pharmaceuticals Announces First Quarter 2024 Financial Results and Affirms 2024 Financial Guidance
PR
Jazz Pharmaceuticals to Present Data across Growing Oncology Pipeline and Portfolio at ASCO 2024
AQ
The PharmaMar Group presents financial results for the first quarter of 2024
AQ
Jazz Pharmaceuticals to Report 2024 First Quarter Financial Results on May 1, 2024
PR
Jazz Pharmaceuticals : Zanidatamab R&D Day
PU
Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024
PR
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action JAZZ
  4. Action
  5. Actualités Jazz Pharmaceuticals, Inc.
  6. Communiqués